Abstract
Accurate data on the Lassa virus (LASV) human case fatality rate (CFR) and the prevalence of LASV in humans, rodents and other mammals are needed for better planning of actions that will ultimately reduce the burden of LASV infection in sub-Saharan Africa. In this systematic review with meta-analysis, we searched PubMed, Scopus, Africa Journal Online, and African Index Medicus from 1969 to 2020 to obtain studies that reported enough data to calculate LASV infection CFR or prevalence. Study selection, data extraction, and risk of bias assessment were conducted independently. We extracted all measures of current, recent, and past infections with LASV. Prevalence and CFR estimates were pooled using a random-effect meta-analysis. Factors associated with CFR, prevalence, and sources of between-study heterogeneity were determined using subgroup and metaregression analyses. This review was registered with PROSPERO, CRD42020166465. We initially identified 1,399 records and finally retained 109 reports that contributed to 291 prevalence records from 25 countries. The overall CFR was 29.7% (22.3–37.5) in humans. Pooled prevalence of LASV infection was 8.7% (95% confidence interval: 6.8–10.8) in humans, 3.2% (1.9–4.6) in rodents, and 0.7% (0.0–2.3) in other mammals. Subgroup and metaregression analyses revealed a substantial statistical heterogeneity explained by higher prevalence in tissue organs, in case-control, in hospital outbreak, and surveys, in retrospective studies, in urban and hospital setting, in hospitalized patients, and in West African countries. This study suggests that LASV infections is an important cause of death in humans and that LASV are common in humans, rodents and other mammals in sub-Saharan Africa. These estimates highlight disparities between sub-regions, and population risk profiles. Western Africa, and specific key populations were identified as having higher LASV CFR and prevalence, hence, deserving more attention for cost-effective preventive interventions.
Highlights
At least 75% of emerging and re-emerging infectious diseases have an animal origin [1]
We selected studies conducted in sub-Saharan Africa (SSA), as defined by the United Nations Statistics Division (UNSD), that represent the habitat of Mastomys natalensis, natural hosts of Lassa virus (LASV) [5]
This systematic review provides a comprehensive overview of the case fatality rate due to LASV in humans and the prevalence of LASV in humans, rodents and other mammals
Summary
At least 75% of emerging and re-emerging infectious diseases have an animal origin [1]. A recent study showed that up to 37.7 million people in 14 countries in sub-Saharan Africa (SSA), in West Africa, were living in areas that were prone to LASV zoonotic transmission, because of the presence of rodent reservoirs in these countries [5]. The LASV is found in other rodents and mammals species in the West Africa [6]. This presence of LASV in non-reservoirs could represent transient or spillover infections [7]. Lassa virus is transmitted from human to human by direct contact with secretions or infected blood, especially in hospitals with relatively high case fatality rates [8,9]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.